Copytele Inc Stock OTC Bulletin Board
Equities
COPY
US2177211099
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
04-18 | Anixa Biosciences Welcomes Sanjay Juneja to Its Cancer Business Advisory Board | CI |
03-12 | Anixa Biosciences, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 98.57M 135M |
---|---|---|---|---|---|
Net income 2024 * | -14M -19.16M | Net income 2025 * | -15M -20.53M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.02
x | P/E ratio 2025 * |
-6.87
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.1% |
Latest transcript on Copytele Inc
Managers | Title | Age | Since |
---|---|---|---|
Amit Kumar
CEO | Chief Executive Officer | 59 | 12-10-31 |
Michael Catelani
DFI | Director of Finance/CFO | 57 | 16-10-31 |
Pamela Garzone
PRN | Corporate Officer/Principal | 69 | 21-09-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Titterton
BRD | Director/Board Member | 79 | 99-06-30 |
Amit Kumar
CEO | Chief Executive Officer | 59 | 12-10-31 |
Emily Gottschalk
BRD | Director/Board Member | 63 | 19-10-22 |
1st Jan change | Capi. | |
---|---|---|
+23.81% | 42.68B | |
-3.31% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+7.89% | 24.94B | |
-19.98% | 18.96B | |
+29.22% | 12.3B | |
-2.78% | 11.95B | |
-1.47% | 11.55B |
- Stock Market
- Equities
- ANIX Stock
- COPY Stock